Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, September 21, 2018
Mylan announced the U.S. launch of Dalfampridine Extended-Release Tablets, 10 mg, the authorized generic version of Acorda's Ampyra.
read more
Thursday, September 20, 2018
Merrimack Pharmaceuticals has received a $5 million milestone payment from Shire, triggered by the sale of Onivyde in the first major non-European, non-Asian country.
read more
Thursday, September 20, 2018
SCOUT has formed a joint venture with Rare Expertise, a company with proprietary data-driven tools for identifying and activating people with rare disorders.
read more
Wednesday, September 19, 2018
Legacy Health has selected Trellis Rx, a leading technology-enabled specialty pharmacy service provider, to help Legacy launch a patient-centered specialty pharmacy program.
read more
Wednesday, September 19, 2018
Just Biotherapeutics and Pandion Therapeutics announced they have entered into an agreement for the development and cGMP clinical manufacturing by Just of Pandion’s lead program.
read more
Wednesday, September 19, 2018
The Virginia Department of Criminal Justice Services announced Qlarion has been awarded a contract to construct a data-sharing and analysis platform that will improve Virginia’s response to the opioid crisis.
read more
Wednesday, September 19, 2018
Emmaus Life Sciences has entered into a distribution agreement with Cardinal Health.
read more
Wednesday, September 19, 2018
Abzena has signed an agreement with Tmunity Therapeutics, a clinical stage T cell therapy company in the development of new Chimeric Antigen Receptor T Cell (CAR-T) therapies.
read more
Tuesday, September 18, 2018
Thermo Fisher Scientific has licensed CRISPR technologies from the Broad Institute and ERS Genomics (foundational University of California IP) to bolster its genome editing intellectual property (IP) portfolio.
read more
Tuesday, September 18, 2018
Integral Molecular and Merus N.V. announced they have entered into a collaboration on multiple undisclosed targets.
read more
Tuesday, September 18, 2018
PharmaCyte Biotech announced its partner, Austrianova, has successfully performed an additional pre-production “engineering run” using the Cell-in-a-Box encapsulated cells that will be used, in combination with low doses of the cancer prodrug ...
read more
Tuesday, September 18, 2018
Aphena Pharma Solutions has expanded its DEA operations and storage in both its Maryland and Tennessee manufacturing locations.
read more
Monday, September 17, 2018
Isotopen Technologien München (ITM) has signed a Research Evaluation and Option Agreement for a worldwide exclusive license with Merck KGaA, Darmstadt, Germany.
read more
Monday, September 17, 2018
PCI Pharma Services announced its exclusive collaboration agreement with CSP Technologies for U.S. clinical trials and stability testing utilizing Activ-Blister packaging solutions.
read more
Monday, September 17, 2018
Nemaura Pharma has entered into a license agreement with a Global Pharma Company to develop 3 new Transdermal Patch products.
read more